PREDICTIVE ONCOLOGY INC (POAI) Stock Price & Overview
NASDAQ:POAI • US74039M4087
The current stock price of POAI is 5.95 USD. Today POAI is up by 0.51%. In the past month the price decreased by -11.72%. In the past year, price decreased by -49.14%.
POAI Key Statistics
- Market Cap
- 88.655M
- P/E
- N/A
- Fwd P/E
- 72.92
- EPS (TTM)
- -120.64
- Dividend Yield
- N/A
POAI Stock Performance
POAI Stock Chart
POAI Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to POAI. When comparing the yearly performance of all stocks, POAI is a bad performer in the overall market: 95.35% of all stocks are doing better.
POAI Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to POAI. POAI has a bad profitability rating. Also its financial health evaluation is rather negative.
POAI Earnings
POAI Forecast & Estimates
For the next year, analysts expect an EPS growth of 99.58% and a revenue growth 569.48% for POAI
POAI Groups
Sector & Classification
POAI Financial Highlights
Over the last trailing twelve months POAI reported a non-GAAP Earnings per Share(EPS) of -120.64. The EPS decreased by -163% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2688.13% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
POAI Ownership
POAI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.08 | 193.084B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.96 | 176.393B | ||
| SYK | STRYKER CORP | 24.11 | 141.687B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.37 | 108.246B | ||
| IDXX | IDEXX LABORATORIES INC | 41.06 | 49.421B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.46 | 48.681B | ||
| BDX | BECTON DICKINSON AND CO | 10.61 | 48.418B | ||
| RMD | RESMED INC | 20.59 | 37.195B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.79 | 35.143B | ||
| DXCM | DEXCOM INC | 26.97 | 27.57B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.99 | 18.52B | ||
| PODD | INSULET CORP | 37.39 | 16.95B | ||
| HOLX | HOLOGIC INC | 15.05 | 16.91B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About POAI
Company Profile
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 23 full-time employees. The company went IPO on 2009-12-18. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy when a tumor sample responds to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Through AI, it uses its proprietary biobank of 150,000+ cancer tumor samples, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of drug development. The firm offers a suite of solutions for oncology drug development from early discovery to clinical trials.
Company Info
PREDICTIVE ONCOLOGY INC
91 43Rd Street, Suite 110
Pittsburgh PENNSYLVANIA 55121 US
CEO: Carl Schwartz
Employees: 23
Phone: 14124321500
PREDICTIVE ONCOLOGY INC / POAI FAQ
What does PREDICTIVE ONCOLOGY INC do?
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 23 full-time employees. The company went IPO on 2009-12-18. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy when a tumor sample responds to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Through AI, it uses its proprietary biobank of 150,000+ cancer tumor samples, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of drug development. The firm offers a suite of solutions for oncology drug development from early discovery to clinical trials.
What is the current price of POAI stock?
The current stock price of POAI is 5.95 USD. The price increased by 0.51% in the last trading session.
Does POAI stock pay dividends?
POAI does not pay a dividend.
What is the ChartMill rating of PREDICTIVE ONCOLOGY INC stock?
POAI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the employee count for POAI stock?
PREDICTIVE ONCOLOGY INC (POAI) currently has 23 employees.